Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2012-03-07 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于会计师事务所改制更名的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change in the name and organizational form of the accounting firm auditing the company. It explicitly states that this change is not a replacement of the audit firm and references the auditor for the 2011 fiscal year. The document is short (538 characters) and serves as a formal notification rather than containing audit results or financial statements. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the auditor's status and not a full audit report or annual report.
2012-03-07 Chinese
关于获准生产新型疫苗的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Inner Mongolia Jinyu Group Co., Ltd. regarding approval to produce new types of vaccines. It contains no financial data, no mention of financial results, no regulatory filings or certifications, and no shareholder or board information. It is a company announcement about a business development related to vaccine production. The document length is only 553 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2012-03-06 Chinese
关于变更投资者热线电话的公告
Regulatory Filings Classification · 100% confidence The document is a short announcement about the change of the company's investor hotline phone number and fax number. It does not contain financial data, management changes, voting results, or any detailed report content. It is a regulatory announcement informing investors of contact information changes. The document length is only 299 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2012-01-09 Chinese
2011年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2011 年第三季度报告" which translates to "2011 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary for the third quarter of 2011. The report is unaudited as stated in the document. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) clearly identifies this as an Interim / Quarterly Report. The document length is substantial (over 14,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2011
2011-10-26 Chinese
为控股子公司金宇保灵生物药品有限公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing a guarantee for a subsidiary's bank loan. It details the guarantee amount, the subsidiary's financial status, and board approval. There is no financial report or detailed financial statements presented, only a disclosure of a financing-related guarantee. This fits the category of Capital/Financing Update (CAP), as it relates to financing activities and guarantees provided by the company. The document length is short and it is not an announcement of a report publication or a certification. Therefore, the best classification is CAP with high confidence.
2011-09-08 Chinese
第七届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the company's board of directors regarding the approval of the 2011 half-year report and the appointment of a securities affairs representative. It includes voting results and details about the meeting. The document does not contain the actual half-year financial report or detailed financial data, but rather announces the board's approval of the interim report and other board decisions. The document length is short (806 characters), and it serves as an official announcement of board resolutions rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting decisions and management appointments.
2011-08-06 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.